agomelatine   Click here for help

GtoPdb Ligand ID: 198

Synonyms: S20098 | Thymanax® | Valdoxan®
Approved drug PDB Ligand
agomelatine is an approved drug (EMA (2009))
Compound class: Synthetic organic
Comment: Agomelatine is a melatonergic (i.e. it acts as a a melatonin receptor agonist) antidepressant, devoid of the side-effects caused by SSRI, SNRI and tricyclic antidepressants. The drug also has low affinity for 5-HT2C receptors.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 38.33
Molecular weight 243.13
XLogP 2.76
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc2c(c1)c(CCNC(=O)C)ccc2
Isomeric SMILES COc1ccc2c(c1)c(CCNC(=O)C)ccc2
InChI InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)
InChI Key YJYPHIXNFHFHND-UHFFFAOYSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
MT1 receptor Primary target of this compound Hs Agonist Full agonist 10.0 – 10.4 pKi - 1-2
pKi 10.0 – 10.4 [1-2]
MT2 receptor Primary target of this compound Hs Agonist Full agonist 9.9 – 10.5 pKi - 1-2
pKi 9.9 – 10.5 [1-2]
5-HT2B receptor Hs Antagonist Antagonist 6.6 pKi - 4
pKi 6.6 [4]
5-HT2C receptor Hs Antagonist Antagonist 6.2 pKi - 4
pKi 6.2 [4]
5-HT2A receptor Hs Antagonist Antagonist 5.4 pKi - 4
pKi 5.4 [4]
Ligand mentioned in the following text fields